Results 51 to 60 of about 15,144 (118)

Immunoexpression of programmed death receptor 1 and its ligands in oral cavity squamous cell carcinoma. [PDF]

open access: yesMed Oral Patol Oral Cir Bucal
Anjos RS   +5 more
europepmc   +1 more source

A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4. [PDF]

open access: yesTheranostics
Kim RK   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy